RenaissanceRe (NYSE:RNR – Get Free Report) had its price target lifted by investment analysts at Mizuho from $352.00 to $358.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a “neutral” rating on the insurance provider’s stock. Mizuho‘s target price would suggest a potential upside of 4.08% from the company’s current price.
Several other brokerages have also recently weighed in on RNR. JPMorgan Chase & Co. dropped their price objective on RenaissanceRe from $360.00 to $355.00 and set a “neutral” rating on the stock in a research note on Friday, October 9th. Weiss Ratings upgraded shares of RenaissanceRe from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday. Morgan Stanley increased their target price on shares of RenaissanceRe from $335.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday. Zacks Research raised shares of RenaissanceRe from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Finally, TD Cowen boosted their price target on shares of RenaissanceRe from $315.00 to $320.00 and gave the stock a “hold” rating in a report on Monday, October 12th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $346.88.
View Our Latest Analysis on RNR
RenaissanceRe Stock Performance
Shares of RenaissanceRe stock opened at $343.98 on Friday. The company has a market cap of $13.90 billion, a PE ratio of 9.89, a price-to-earnings-growth ratio of 0.88 and a beta of 0.11. RenaissanceRe has a 52 week low of $251.60 and a 52 week high of $363.84. The business has a 50 day moving average price of $339.27 and a 200-day moving average price of $315.35. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 0.22.
RenaissanceRe (NYSE:RNR – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The insurance provider reported $12.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.56 by $2.15. RenaissanceRe had a return on equity of 21.13% and a net margin of 16.25%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.78 billion. During the same quarter in the prior year, the company posted $15.62 earnings per share. Equities analysts anticipate that RenaissanceRe will post 49.86 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RNR. Ashurst Perkins Coie Trust Co bought a new position in RenaissanceRe during the third quarter valued at $26,000. Elevation Wealth Partners LLC increased its position in RenaissanceRe by 90.0% in the third quarter. Elevation Wealth Partners LLC now owns 95 shares of the insurance provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Continuum Advisory LLC purchased a new stake in RenaissanceRe in the second quarter worth $38,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of RenaissanceRe in the second quarter valued at $42,000. Finally, Heritage Family Offices LLP bought a new stake in shares of RenaissanceRe in the third quarter valued at $51,000. 99.97% of the stock is currently owned by hedge funds and other institutional investors.
Latest RenaissanceRe News
Investors following RNR have been watching these news items:
- Positive Sentiment: Zacks Research increased estimates for multiple future quarters, including Q4 2027 EPS to $11.72 from $9.75, and FY2027 EPS to $42.10 from $39.40. Its Q4 2026 estimate was most recently nudged up to $9.85. These revisions and the Strong Buy rating provide the clearest positive news for RNR. RenaissanceRe earnings forecast raised
- Neutral Sentiment: RenaissanceRe renewed its $500 million revolving credit facility, maintaining access to financing; the announcement does not indicate a material change to its business outlook. Credit facility renewal
- Negative Sentiment: Zacks Research’s FY2026 EPS estimate of $49.22 is below the stated consensus of $49.86, a potential counterpoint to the upbeat rating and quarterly forecast revisions.
About RenaissanceRe
RenaissanceRe Holdings Ltd. is a Bermuda-based provider of reinsurance and insurance, serving clients around the world. The company focuses on helping insurers and other businesses manage risks that can be difficult to predict or absorb. Its main offerings include property catastrophe reinsurance, which helps protect insurers against losses from events such as hurricanes and earthquakes, as well as casualty and specialty reinsurance and insurance. RenaissanceRe also manages capital on behalf of third-party investors and uses risk modeling to assess and manage its exposure.
Further Reading
- Five stocks we like better than RenaissanceRe
- Tesla and SpaceX May Form a $3.4 Trillion Giant, But Who Really Benefits?
- 2 Utility Stocks May Offer Relief From AI Volatility, But Rates Are the Real Story
- Home Depot Posts a Q3 Double Beat, But Is Its Rebound Built to Last?
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.
